| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Common Stock | 21.2k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 3.4k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 499 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 3.5k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 2.4k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 2.2k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 4.8k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 864 | $0.00 | $0 | | 05/31/2023 |
| 03/14/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (Right to Buy) | 576 | $68.50 | $39.5k | | 03/14/2023 |
| 01/26/2023 | Pulmatrix, Inc. | PULM | Grant | Stock Option (Right to Buy) | 1.7k | $3.99 | $6.8k | | 01/26/2023 |
| 01/04/2023 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 62 | $28.54 | $1.8k | | 01/04/2023 |
| 01/04/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 12.8k | $0.00 | $0 | | 01/04/2023 |
| 06/27/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 3.1k | $0.37 | $1.1k | | 06/27/2022 |
| 01/27/2022 | Pulmatrix, Inc. | PULM | Grant | Stock Option (Right to Buy) | 22.1k | $0.37 | $8.2k | | 01/27/2022 |
| 01/04/2022 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 3.5k | $1.30 | $4.5k | | 01/03/2022 |
| 01/03/2022 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 238k | $1.37 | $326.1k | | 01/03/2022 |
| 10/26/2021 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 12.5k | $1.80 | $22.6k | | 10/26/2021 |
| 06/28/2021 | Kala Pharmaceuticals, Inc. | KALA | Sale | Common Stock | 2.9k | $5.77 | $16.8k | | 06/28/2021 |
| 01/28/2021 | Pulmatrix, Inc. | PULM | Grant | Stock Option (Right to Buy) | 15k | $1.47 | $22k | | 01/28/2021 |
| 01/04/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 110k | $6.86 | $754.6k | | 01/04/2021 |
| 01/04/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 27.5k | $0.00 | $0 | | 01/04/2021 |
| 10/26/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 81k | $0.00 | $0 | | 06/05/2020 |
| 10/22/2020 | Kala Pharmaceuticals, Inc. | KALA | Purchase | Common Stock | 40 | $7.60 | $304 | By son | 06/05/2020 |
| 10/01/2020 | Pulmatrix, Inc. | PULM | Grant | Stock Option (Right to Buy) | 30k | $1.14 | $34.2k | | 10/01/2020 |
| 06/25/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 19k | $0.00 | $0 | | 06/25/2020 |
| 06/05/2020 | Kala Pharmaceuticals, Inc. | KALA | Purchase | Common Stock | 2 | $13.39 | $26.8 | By son | 06/05/2020 |
| 03/16/2020 | Kala Pharmaceuticals, Inc. | KALA | Purchase | Common Stock | 10k | $5.75 | $57.5k | | 03/16/2020 |
| 01/02/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 120k | $3.84 | $460.8k | | 01/02/2020 |
| 10/12/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 175k | $3.45 | $603.8k | | 10/12/2019 |
| 01/02/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 175k | $5.19 | $908.2k | | 01/02/2019 |
| 02/07/2018 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 25k | $12.86 | $321.5k | | 02/07/2018 |
| 11/20/2017 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 172k | $19.60 | $3.4M | | 11/20/2017 |